TAVI patients with bystander coronary artery disease should receive PCI: pros and cons
EuroIntervention
.
2024 Nov 18;20(22):1366-1369.
doi: 10.4244/EIJ-E-24-00054.
Authors
Josep Rodés-Cabau
1
2
,
Marisa Avvedimento
1
,
Benedict McDonaugh
3
4
,
Tiffany Patterson
3
4
Affiliations
1
Quebec Heart and Lung Institute, Laval University, Quebec City, QC, Canada.
2
Hospital Clínic Barcelona, Barcelona, Spain.
3
Cardiovascular Department, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
4
Cardiovascular Department, Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom.
PMID:
39552486
PMCID:
PMC11556398
(available on
2025-11-18
)
DOI:
10.4244/EIJ-E-24-00054
No abstract available